387350-82-5 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(4-ISOPROPOXYPHENYL)METHANAMINE is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the formation of complex organic molecules that are vital in medicinal chemistry.
Used in Organic Compounds Synthesis:
In the field of organic chemistry, 1-(4-ISOPROPOXYPHENYL)METHANAMINE is used as a building block for the creation of diverse organic compounds, leveraging its reactive functional groups to form new chemical entities.
Used in Research and Development:
1-(4-ISOPROPOXYPHENYL)METHANAMINE is utilized in research settings to explore its chemical properties and potential applications, including its reactivity, stability, and interactions with other molecules.
Used in Industrial Processes:
1-(4-ISOPROPOXYPHENYL)METHANAMINE is employed in various industrial processes due to its versatility and the ability to be integrated into the production of a wide range of materials and end products.
Used in Material Production:
1-(4-ISOPROPOXYPHENYL)METHANAMINE is used in the production of materials and products, capitalizing on its chemical structure to enhance or impart specific characteristics to these materials.
Check Digit Verification of cas no
The CAS Registry Mumber 387350-82-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,7,3,5 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 387350-82:
(8*3)+(7*8)+(6*7)+(5*3)+(4*5)+(3*0)+(2*8)+(1*2)=175
175 % 10 = 5
So 387350-82-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H15NO/c1-8(2)12-10-5-3-9(7-11)4-6-10/h3-6,8H,7,11H2,1-2H3
387350-82-5Relevant academic research and scientific papers
BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS BLOCKERS OF CALCIUM CHANNELS
-
Page/Page column 171, (2010/11/28)
The invention relates to piperidinyl and hexahydroazepinyl compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein R1-R3, Z and q are defined as set forth in the specification. The inve
